Postbiotics: emerging therapeutic approach in diabetic retinopathy
Frontiers in Microbiology · 04.03.2024 · 15
DOI: 10.3389/fmicb.2024.1359949 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 04.03.2024. Verfasst von Qin Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diabetic retinopathy (DR) is a prevalent microvascular complication in diabetic patients that poses a serious risk as it can cause substantial visual impairment and even vision loss. Due to the prolonged onset of DR, lengthy treatment duration, and limited therapeutic effectiveness, it is extremely important to find a new strategy for the treatment of DR. Postbiotic is an emerging dietary supplement which consists of the inactivate microbiota and its metabolites. Numerous animal experiments have demonstrated that intervention with postbiotics reduces hyperglycemia, attenuates retinal peripapillary and endothelial cell damage, improves retinal microcirculatory dysfunction, and consequently delays the progression of DR. More strikingly, unlike conventional probiotics and prebiotics, postbiotics with small molecules can directly colonize the intestinal epithelial cells, and exert heat-resistant, acid-resistant, and durable for storage. Despite few clinical significance, oral administration with postbiotics might become the effective management for the prevention and treatment of DR. In this review, we summarized the basic conception, classification, molecular mechanisms, and the advances in the therapeutic implications of postbiotics in the pathogenesis of DR. Postbiotics present great potential as a viable adjunctive therapy for DR.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, China.
- Key Laboratory of Experimental Animal and Safety Evaluation, Hangzhou Medical College, Hangzhou, China.
- Animal Laboratory Center, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
- Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Hangzhou, China.
Zitieren
APA
Chen, Q., Li, X. J., Xie, W., Su, Z. A., Qin, G. M., & Yu, C. H. (2024). Postbiotics: emerging therapeutic approach in diabetic retinopathy. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1359949
Vancouver
Chen Q, Li XJ, Xie W, Su ZA, Qin GM, Yu CH. Postbiotics: emerging therapeutic approach in diabetic retinopathy. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1359949
BibTeX
@article{Chen2024,
author = {Chen, Qin and Li, Xue-Jian and Xie, Wei and Su, Zhao-An and Qin, Guang-Ming and Yu, Chen-Huan},
title = {Postbiotics: emerging therapeutic approach in diabetic retinopathy},
journal = {Frontiers in Microbiology},
year = {2024},
volume = {15},
doi = {10.3389/fmicb.2024.1359949}
}
EUVIMED